Skip to main content

With $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipeline

Looking long term, the company says, it cuts 49 jobs as it pushes multiple programs deeper into clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.